These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34485116)
1. Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients. Zhang Y; Wang H; Xu X; Liu H; Hao T; Yin S; Zhang C; He Y Front Oncol; 2021; 11():668707. PubMed ID: 34485116 [TBL] [Abstract][Full Text] [Related]
2. LILRB1 Xu X; Yin S; Wang Y; Zhu Q; Zheng G; Lu Y; Li T; Zhu C Int Immunopharmacol; 2023 Jun; 119():110162. PubMed ID: 37075669 [TBL] [Abstract][Full Text] [Related]
3. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients. Zhang H; Li R; Cao Y; Gu Y; Lin C; Liu X; Lv K; He X; Fang H; Jin K; Fei Y; Chen Y; Wang J; Liu H; Li H; Zhang H; He H; Zhang W Ann Surg; 2022 Apr; 275(4):e626-e635. PubMed ID: 32541216 [TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. Xu Y; Zeng H; Jin K; Liu Z; Zhu Y; Xu L; Wang Z; Chang Y; Xu J J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338085 [TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813 [TBL] [Abstract][Full Text] [Related]
6. Poor clinical outcomes and immunoevasive contexture in SIRPĪ± Xu Z; Zeng H; Liu Z; Jin K; Chang Y; Wang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J Urol Oncol; 2022 Mar; 40(3):109.e11-109.e20. PubMed ID: 34600802 [TBL] [Abstract][Full Text] [Related]
7. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer. Liu X; Cao Y; Li R; Gu Y; Chen Y; Qi Y; Lv K; Wang J; Yu K; Lin C; Liu H; Zhang H; He H; Chen L; Zhang P; Shen Z; Qin J; Sun Y; Li H; Huang H; Zhang W; Xu J Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848 [TBL] [Abstract][Full Text] [Related]
8. Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma. Zou R; Zhong X; Liang K; Zhi C; Chen D; Xu Z; Zhang J; Liao D; Lai M; Weng Y; Peng H; Pang X; Ji Y; Ke Y; Zhang H; Wang Z; Wang Y BMC Cancer; 2023 May; 23(1):403. PubMed ID: 37142967 [TBL] [Abstract][Full Text] [Related]
9. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression. Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762 [TBL] [Abstract][Full Text] [Related]
10. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma. Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344 [TBL] [Abstract][Full Text] [Related]
11. Relationship of tumour-associated macrophages with poor prognosis in Wilms' tumour. Tian K; Wang X; Wu Y; Wu X; Du G; Liu W; Wu R J Pediatr Urol; 2020 Jun; 16(3):376.e1-376.e8. PubMed ID: 32299765 [TBL] [Abstract][Full Text] [Related]
12. Blockade of DC-SIGN Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149 [TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579 [No Abstract] [Full Text] [Related]
14. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008 [TBL] [Abstract][Full Text] [Related]
15. Elevated Wang D; Deng L; Xu X; Ji Y; Jiao Z Genet Test Mol Biomarkers; 2021 Mar; 25(3):236-246. PubMed ID: 33734892 [No Abstract] [Full Text] [Related]
16. Tumor-infiltrating podoplanin Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer. Su P; Jiang L; Zhang Y; Yu T; Kang W; Liu Y; Yu J Cancer Cell Int; 2022 Sep; 22(1):290. PubMed ID: 36151545 [TBL] [Abstract][Full Text] [Related]
18. CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy. Chang J; Lin S; Mao Y; Xu Y; Zhang Z; Wu Q; Chen Y; Wei Y; Feng Q; Xu J Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230570 [TBL] [Abstract][Full Text] [Related]
19. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages. Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473 [TBL] [Abstract][Full Text] [Related]
20. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma. Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]